CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $5,999,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,999,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-15 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +87,500 | 87,500 | ||
| 2022-03-15 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +87,500 | 87,500 | ||
| 2022-03-15 | Levine Mitchell S Chief Financial Officer | Purchase | +25,000 | $1.17 | $29K | 87,080 |
| 2021-04-28 | Levine Mitchell S Chief Financial Officer | Exercise or conversion | +20,000 | 66,700 | ||
| 2021-04-28 | Levine Mitchell S Chief Financial Officer | Shares withheld for taxes | −4,620 | 62,080 | ||
| 2021-04-28 | Levine Mitchell S Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −20,000 | 0 | ||
| 2021-02-25 | Levine Mitchell S Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +255,000 | $5.34 | $1.4M | 255,000 |
| 2020-12-11 | Levine Mitchell S CFO | Grant or award | +10,121 | 46,700 | ||
| 2020-09-12 | Levine Mitchell S CFO | Purchase | +10,000 | $2.01 | $20K | 13,495 |
| 2020-08-03 | Levine Mitchell S Chief Financial Officer | Purchase | +10,000 | $1.32 | $13K | 36,579 |
| 2020-04-28 | Levine Mitchell S Chief Financial Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2020-04-28 | Levine Mitchell S Chief Financial Officer | Grant or award · Restricted Stock Units | −20,000 | 20,000 | ||
| 2020-03-14 | Levine Mitchell S Chief Financial Officer | Exercise or conversion | +20,000 | 33,495 | ||
| 2020-03-14 | Levine Mitchell S Chief Financial Officer | Shares withheld for taxes | −6,916 | 26,579 | ||
| 2020-03-14 | Levine Mitchell S Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −20,000 | 0 | ||
| 2020-02-10 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to purchase common stock | +204,000 | 204,000 | ||
| 2019-09-12 | Levine Mitchell S CFO | Purchase | +10,000 | $2.01 | $20K | 13,495 |
| 2019-09-12 | Levine Mitchell S Chief Financial Officer | Purchase | +10,000 | $2.01 | $20K | 10,000 |
| 2019-03-14 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +245,000 | 245,000 | ||
| 2019-03-14 | Levine Mitchell S Chief Financial Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 |
Page 1 of 2 · 26 trades